LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
复制标题
LncRNA RP11-436H11.5作为竞争性内源RNA,通过海绵miR-335-5p上调BCL-W表达并促进肾细胞癌的增殖和侵袭
DOI:
10.1186/s12943-017-0735-3
复制
发表时间:
2017-10-25
期刊:
影响因子:
37.3
通讯作者:
Fei X
中科院分区:
文献类型:
--
作者:
Wang K;Jin W;Song Y;Fei X
Accumulating evidence indicates that long non-coding RNAs (lncRNAs) play a crucial role in tumorigenesis. Here, we report a novel lncRNA, RP11-436H11.5, that regulates renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-335-5p. Expression of lncRNA RP11-436H11.5 was determined by a qRT-PCR assay in RCC tissues. RCC cell proliferation and invasion were measured by a cell proliferation assay and a transwell invasion assay. Expression of BCL-W was detected by a western blot assay. Interactions between lncRNA RP11-436H11.5 and miR-335-5p were measured by a luciferase reporter assay and a RNA-pull down assay. In vivo experiments were used to detect tumor formation. In this study, the qRT-PCR results illustrated that lncRNA RP11-436H11.5 was more highly expressed in RCC tissues than in adjacent normal renal tissues. The results of survival analysis indicated that patients in the high lncRNA RP11-436H11.5 group presented significantly worse outcomes compared with those in the low lncRNA RP11-436H11.5 group. Downregulation of lncRNA RP11-436H11.5 suppressed RCC cell proliferation and invasion in vitro and in vivo. Luciferase reporter assay results demonstrated that lncRNA RP11-436H11.5 enhanced BCL-W expression by regulating miR-335-5p expression. LncRNA RP11-436H11.5 could function as a miR-335-5p decoy to derepress expression of BCL-W. LncRNA RP11-436H11.5 could function as a competing endogenous RNA to promote RCC cell proliferation and invasion, which might serve as a therapeutic application to suppress RCC progression.
登录
查看更多内容
DOI:
10.1186/s13046-016-0297-z
发表时间:
2016-01-29
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Wang P;Wu T;Zhou H;Jin Q;He G;Yu H;Xuan L;Wang X;Tian L;Sun Y;Liu M;Qu L
通讯作者:
Qu L
影响因子:
--
作者:
Jia J;Li F;Tang XS;Xu S;Gao Y;Shi Q;Guo W;Wang X;He D;Guo P
通讯作者:
Guo P
影响因子:
8.8
作者:
Gruenwald, V.;Seidel, C.;Fenner, M.;Ganser, A.;Busch, J.;Weikert, S.
通讯作者:
Weikert, S.
影响因子:
50.3
作者:
Qu, Le;Ding, Jin;Wang, Lin-Hui
通讯作者:
Wang, Lin-Hui
影响因子:
64.5
作者:
Salmena L;Poliseno L;Tay Y;Kats L;Pandolfi PP
通讯作者:
Pandolfi PP